InnovAge Holding Corp., a Denver company that runs government-funded care programs for older adults in several states, has agreed to pay $36 million to settle federal and state allegations that it failed for years to get patients timely appointments with medical specialists, the Justice Department announced Tuesday.

The allegations span May 2016 to October 2022. In that period, the government said, InnovAge did not keep enough specialists in its provider networks and in thousands of instances failed to promptly schedule appointments or consultations in fields such as oncology, cardiology, surgery and neurology.

The government pointed to InnovAge's own records. Federal and state authorities alleged that the company's internal reports on physicians' orders routinely showed numerous overdue specialist referrals, and that several senior InnovAge physicians complained that the scheduling delays were harming patients, exposing clinicians to legal risk and leaving the company out of compliance with requirements of the Centers for Medicare & Medicaid Services. Internal audits found significant delays, with many orders more than a year outstanding, according to the department. It also noted that the claims are allegations only and that there has been no determination of liability.

InnovAge operates under the Program of All-Inclusive Care for the Elderly, known as PACE, a joint Medicare and Medicaid program. The Centers for Medicare & Medicaid Services pays a PACE organization a fixed monthly amount for each Medicare beneficiary it enrolls, the department explained, and in return the organization must provide comprehensive care, with every service delivered as quickly as the participant's health requires. InnovAge has PACE centers in California, Colorado, New Mexico and Virginia, among other states.

Of the total, about $25.7 million goes to the federal government and a combined $10.3 million to Colorado, California, New Mexico and Virginia. The agreement also settles whistleblower suits that two former InnovAge employees filed in federal court in Colorado under the False Claims Act and similar state laws, which let private parties sue on the government's behalf and collect part of any recovery. Their share of the federal settlement will be $4.5 million.

"This historic, first-of-its-kind settlement demonstrates the Civil Division's commitment to combating healthcare fraud by PACE organizations," Acting Assistant Attorney General Jonathan D. Guynn of the department's Civil Division said in the announcement. Peter McNeilly, the U.S. attorney for Colorado, said that "elderly patients suffer when PACE providers like InnovAge do not fulfill their obligations to schedule patient visits with medical specialists in a timely manner."

The department cast the case as part of a broader drive against fraud in federal programs, citing the Task Force to Eliminate Fraud and the National Fraud Enforcement Division that the administration launched this year and saying its False Claims Act work would support both. The Fraud Section of the Civil Division's Commercial Litigation Branch and the U.S. attorney's office in Colorado handled the matter, with help from the Health and Human Services inspector general's office, the department said.

InnovAge had already told investors the matter was settled. In its quarterly report filed Nov. 3, the company said it received a civil investigative demand from the Colorado attorney general in July 2021 under the state's Medicaid False Claims Act, and that the Justice Department followed in February 2022 with a federal demand seeking records on audits, billing, orders tracking, and the quality and timeliness of patient services. In October, the company executed settlement agreements with the United States and, separately, with the four states, and it paid about $36.9 million in total at the end of that month, the filing said. That figure is slightly higher than the $36 million in the government's announcement. The agreements release certain civil and administrative monetary claims arising from the conduct they cover.

As of Sept. 30, InnovAge carried a litigation accrual of about $36.7 million on its balance sheet, substantially all of it tied to the state and federal demands, according to the report.